Evaluation of the Impact of Training on Outcome Measures in Subjects With Painful Diabetic Neuropathy
Status:
Unknown status
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The difference between active treatment and placebo in a clinical trial of an analgesic
appears to depend on a variety of factors other than the actual efficacy of the drug itself,
including various aspects of study design and conduct. One potential such factor is how
information about the study is presented to research staff and patients. The purpose of this
study is to examine the impact of different presentations of information on the difference
between pregabalin and placebo observed in a clinical trial in patients with painful diabetic
neuropathy.